Peroxisome proliferator-activated receptor-γ doesn’t modify altered electrophysiological properties of the CA1 pyramidal neurons in a rat model of hepatic cirrhosis-Reference-Cited by-同舟云学术

Peroxisome proliferator-activated receptor-γ doesn’t modify altered electrophysiological properties of the CA1 pyramidal neurons in a rat model of hepatic cirrhosis

Published:2022-08-09 Issue:8 Volume:37 Page:2687-2697
ISSN:0885-7490
Container-title:Metabolic Brain Disease
language:en
Short-container-title:Metab Brain Dis

Author:

Tahamtan Mahshid,Aghaei Iraj,Shabani Mohammad,Nazari Abbas,Pooladvand Vahid,Razavinasab Moazamehosadat^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cellular and Molecular Neuroscience,Neurology (clinical),Biochemistry

Link

https://link.springer.com/content/pdf/10.1007/s11011-022-01057-7.pdf

Reference68 articles.

1. Agarwal R (2006) Anti-inflammatory effects of short-term pioglitazone therapy in men with advanced diabetic nephropathy. Am J Physiology-Renal Physiol 290:F600–F605

2. Aghaei I, Shabani M, Doustar N, Nazeri M, Dehpour A (2014) Peroxisome proliferator-activated receptor-γ activation attenuates motor and cognition impairments induced by bile duct ligation in a rat model of hepatic cirrhosis. Pharmacol Biochem Behav 120:133–139

3. Aghaei I, Nazeri M, Shabani M, Mossavinasab M, Mirhosseini FK, Nayebpour M, Dalili A (2015) Erythropoietin ameliorates the motor and cognitive function impairments in a rat model of hepatic cirrhosis. Metab Brain Dis 30:197–204

4. Aghaei I, Hajali V, Dehpour A, Haghani M, Sheibani V, Shabani M (2016) Alterations in the intrinsic electrophysiological properties of Purkinje neurons in a rat model of hepatic encephalopathy: Relative preventing effect of PPARγ agonist. Brain Res Bull 121:16–25

5. Aghaei I, Hajali V, Haghani M, Vaziri Z, Moosazadeh M, Shabani M (2019) Peroxisome proliferator-activated receptor-γ activation attenuates harmaline-induced cognitive impairments in rats. J Clin Neurosci 59:276–283